OLEJAROVA, Marta, Zelmira MACEJOVA, Spyridon GKALPAKIOTIS, Leona PROCHÁZKOVÁ, Zoltan TOTH and Pavel PRAGR. Reproductive Healthcare in Women with Rheumatoid Arthritis and Psoriatic Diseases in Routine Clinical Practice: Survey Results of Rheumatologists and Dermatologists. RHEUMATOLOGY AND THERAPY. NEW YORK: SPRINGER, 2022, vol. 9, No 6, p. 1575-1586. ISSN 2198-6576. Available from: https://dx.doi.org/10.1007/s40744-022-00488-z.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Reproductive Healthcare in Women with Rheumatoid Arthritis and Psoriatic Diseases in Routine Clinical Practice: Survey Results of Rheumatologists and Dermatologists
Authors OLEJAROVA, Marta (203 Czech Republic, guarantor), Zelmira MACEJOVA (203 Czech Republic), Spyridon GKALPAKIOTIS, Leona PROCHÁZKOVÁ (203 Czech Republic, belonging to the institution), Zoltan TOTH and Pavel PRAGR (203 Czech Republic).
Edition RHEUMATOLOGY AND THERAPY, NEW YORK, SPRINGER, 2022, 2198-6576.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30226 Rheumatology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.800
RIV identification code RIV/00216224:14110/22:00128213
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s40744-022-00488-z
UT WoS 000857814200002
Keywords in English Women of childbearing age; Family planning; Chronic inflammatory disease; Rheumatoid arthritis; Psoriatic arthritis; Psoriasis; Reproductive health
Tags 14110116, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 23/1/2023 10:19.
Abstract
Introduction The proportion of women being treated with biologics is growing. However, data on treatment recommendation awareness among treating physicians and women who are considering pregnancy and family planning are limited. In this study, we used a questionnaire survey to learn how rheumatologists and dermatologists address women's needs for family planning, pregnancy, and breastfeeding, as well as their possible concerns with concurrent inflammatory rheumatic disease or psoriasis. Methods A 55-question (in English) survey aimed at identifying surveyed physicians' current practices regarding the reproductive health needs of women with rheumatoid arthritis, psoriasis, or psoriatic arthritis. This survey included 82 rheumatologists and 38 dermatologists from the Czech Republic, Hungary, and Slovakia. Results The proportion of female patients of reproductive age with the moderate-to-severe disease was 10-30% of all patients treated by the respondents. At the time of diagnosis, approximately two-thirds of the respondents discussed family planning with their patients. Rheumatologists collaborated with other specialists more frequently than dermatologists and gynecologist-obstetricians. Half of the rheumatologists revised systemic treatment 6 months before the patient planned to become pregnant, whereas dermatologists appear to act much sooner. Rheumatologists chose systemic glucocorticoids as the first-line treatment for pregnancy flares, whereas dermatologists chose topical corticosteroids. Congresses and interdisciplinary forums were rated the most valuable sources of information by physicians. Conclusions There is a need for more holistic, multidisciplinary, collaborative, and integrated communication between clinicians and women of childbearing age. Physicians should consider the implications of these conditions and medical treatment for women of childbearing age and family planning for those with rheumatoid arthritis and psoriatic disease. Patient-centered care that includes patients' reproductive choices should be a routine clinical practice.
PrintDisplayed: 21/5/2024 17:52